Antidepressants reduce neuroinflammatory responses and astroglial alpha‐synuclein accumulation in a transgenic mouse model of multiple system atrophy
Open accessThe DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Abstract
Multiple system atrophy (MSA) is a neurodegenerative disease characterized by the pathological accumulation of alpha‐synuclein (α‐syn) within oligodendroglial cells. This accumulation is accompanied by neuroinflammation with astrogliosis and microgliosis, that leads to neuronal death and subsequent parkinsonism and dysautonomia. Antidepressants have been explored as neuroprotective agents as they normalize neurotrophic factor levels, increase neurogenesis and reduce neurodegeneration, but their anti‐inflammatory properties have not been fully characterized. We analyzed the anti‐inflammatory profiles of three different antidepressants (fluoxetine, olanzapine and amitriptyline) in the MBP1‐hα‐syn transgenic (tg) mouse model of MSA. We observed that antidepressant treatment decreased the number of α‐syn‐positive cells in the basal ganglia of 11‐month‐old tg animals. This reduction was accompanied with a similar decrease in the colocalization of α‐syn with astrocyte markers in this brain structure. Consistent with these results, antidepressants reduced astrogliosis in the hippocampus and basal ganglia of the MBP1‐hα‐syn tg mice, and modulated the expression levels of key cytokines that were dysregulated in the tg mouse model, such as IL‐1β. In vitro experiments in the astroglial cell line C6 confirmed that antidepressants inhibited NF‐κB translocation to the nucleus and reduced IL‐1β protein levels. We conclude that the anti‐inflammatory properties of antidepressants in the MBP1‐hα‐syn tg mouse model of MSA might be related to their ability to inhibit α‐syn propagation from oligodendrocytes to astroglia and to regulate transcription factors involved in cytokine expression. Our results suggest that antidepressants might be of interest as anti‐inflammatory and α‐syn‐reducing agents for MSA and other α‐synucleinopathies. GLIA 2014;62:317–337
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Darnell, J. E., Kerr, L. M., & Stark, G. R. (1994) · Science · doi:10.1126/science.8197455 · Cited by 6,080 · cited 4×
“…of the antidepressants used in this study normalized levels of cytokines that signal through the Jak-STAT pathway, such as G-CSF, IFN-c and IL-13 (Darnell et al., 1994; Tian et al., 1996; Welham et al., 1995), suggesting that NF-jB regulation might be mechanistically involved in the…”
BackgroundInfluentialSecond consensus statement on the diagnosis of multiple system atrophy
Gilman, S., Wenning, G. K., Low, P. A., Brooks, D. J., Mathias, C. J., Trojanowski, J. Q., Wood, N. W., Colosimo, C., Dürr, A., Fowler, C. J., et al. (2008) · Neurology · doi:10.1212/01.wnl.0000324625.00404.15 · Cited by 3,140
Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus
Malberg, J. E., Eisch, A. J., Nestler, E. J., & Duman, R. S. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-24-09104.2000 · Cited by 3,111
Inflammatory Blockade Restores Adult Hippocampal Neurogenesis
Monje, M. L., Toda, H., & Palmer, T. D. (2003) · Science · doi:10.1126/science.1088417 · Cited by 2,426
Nibuya, M., Morinobu, S., & Duman, R. (1995) · The Journal of Neuroscience · doi:10.1523/jneurosci.15-11-07539.1995 · Cited by 2,109 · cited 2×
“…antidepressants are good candidates for the treatment of neu- rodegenerative diseases, as they do not only normalize mood changes, but they also reduce neurodegeneration, increase neurogenesis and restore trophic factor levels (Haynes et al., 2004; Nibuya et al., 1995; Santarelli et al., 2003).”
BackgroundLi, J.-Y., Englund, E., Holton, J. L., Soulet, D., Hagell, P., Lees, A. J., Lashley, T., Quinn, N. P., Rehncrona, S., Björklund, A., et al. (2008) · Nature Medicine · doi:10.1038/nm1746 · Cited by 1,845
Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease.
Griffin, W. S., Stanley, L. C., Ling, C., White, L., MacLeod, V, Perrot, L. J., White, C. L., & Araoz, C. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.19.7611 · Cited by 1,777 · cited 1×
“…a pro-inflammatory cytokine that is believed to drive the neuroinflammatory process (Mrak, 2009; Rothwell and Luheshi, 2000), and that is upregulated in AD, PD, multiple sclerosis, and other neurodegenerative diseases (Griffin et al., 1989, 2006; Rothwell and Luheshi, 2000; Shaftel et al., 2007).”
BackgroundInclusion formation and neuronal cell death through neuron-to-neuron transmission of α-synuclein
Desplats, P., Lee, H.-J., Bae, E.-J., Patrick, C., Rockenstein, E., Crews, L., Spencer, B., Masliah, E., & Lee, S.-J. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0903691106 · Cited by 1,485
Self-citationMCGEER, P., & MCGEER, E. (1995) · Brain Research Reviews · doi:10.1016/0165-0173(95)00011-9 · Cited by 1,287
Zhang, W., Wang, T., Pei, Z., Miller, D. S., Wu, X., Block, M. L., Wilson, B., Zhang, W., Zhou, Y., Hong, J.-S., et al. (2005) · The FASEB Journal · doi:10.1096/fj.04-2751com · Cited by 1,265 · cited 1×
“In vitro studies have confirmed that extracellular a-syn triggers microglial and astroglial activation (Fellner et al., 2013; Zhang et al., 2005).”
BackgroundInflammation in Neurodegenerative Disease—A Double-Edged Sword
Wyss-Coray, T., & Mucke, L. (2002) · Neuron · doi:10.1016/s0896-6273(02)00794-8 · Cited by 1,235 · cited 1×
“…produces cytokines, such as interleukin-1a (IL-1a), IL-1b, IL-6, tumor necrosis factor-a (TNF-a), chemokines such as IL-8, as well as inflammatory markers such as intercellular-adhesion molecule-1 (ICAM-1), all of which are known to contribute to tissue injuries (Wyss-Coray and Mucke, 2002).”
BackgroundRole of Pro-Inflammatory Cytokines Released from Microglia in Neurodegenerative Diseases
Smith, J. A., Das, A., Ray, S. K., & Banik, N. L. (2012) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2011.10.004 · Cited by 1,165
Shimizu, E., Hashimoto, K., Okamura, N., Koike, K., Komatsu, N., Kumakiri, C., Nakazato, M., Watanabe, H., Shinoda, N., Okada, S.-I., et al. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(03)00181-1 · Cited by 1,151 · cited 2×
“…how antidepressants exert their neuroprotective actions, such as augmentation of antioxidant defenses (Behr et al., 2012; Kotan et al., 2011), BDNF upregulation (Balu et al., 2008; Shimizu et al., 2003; Ubhi et al., 2012) and noradrenergic regulation (Cohen et al., 1980; Laifenfeld et al., 2005).”
BackgroundMicroglial cell origin and phenotypes in health and disease
Saijo, K., & Glass, C. K. (2011) · Nature Reviews Immunology · doi:10.1038/nri3086 · Cited by 1,100
Microglia and neuroinflammation: a pathological perspective
Streit (2004) · Journal of Neuroinflammation · doi:10.1186/1742-2094-1-14 · Cited by 1,039
Papp, M. I., Kahn, J. E., & Lantos, P. L. (1989) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(89)90219-0 · Cited by 991 · cited 2×
“Multiple system atrophy (MSA) is a a-synucleinopathy characterized by the accumulation of a-syn aggregates within oligodendroglial cells (Dickson et al., 1999; Papp et al., 1989; Spillantini, 1999; Wakabayashi et al., 1998b), which is associated to neuronal loss in the striatum, cerebellum, brainstem and cortex, and t…”
BackgroundLithium induces autophagy by inhibiting inositol monophosphatase
Sarkar, S., Floto, R. A., Berger, Z., Imarisio, S., Cordenier, A., Pasco, M., Cook, L. J., & Rubinsztein, D. C. (2005) · The Journal of Cell Biology · doi:10.1083/jcb.200504035 · Cited by 985 · cited 2×
“, 2011) and it induces the clearance of protein aggregates by autophagy (Sarkar et al., 2005).”
BackgroundPharmacological profile of antidepressants and related compounds at human monoamine transporters
Tatsumi, M., Groshan, K., Blakely, R. D., & Richelson, E. (1997) · European Journal of Pharmacology · doi:10.1016/s0014-2999(97)01393-9 · Cited by 939
Lee, H.-J., Suk, J.-E., Patrick, C., Bae, E.-J., Cho, J.-H., Rho, S., Hwang, D., Masliah, E., & Lee, S.-J. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.081125 · Cited by 877 · cited 13×
“It is also important to note that a-syn accumulation is not restricted to neurons or oligodendrocytes, but it has also been observed within astroglial cells in MSA (Wenning and Jellinger, 2005), dementia with Lewy bodies (DLB) and PD (Braak et al., 2007; Lee et al., 2010b).”
BackgroundInfluentialSelf-citationHansen, C., Angot, E., Bergström, A.-L., Steiner, J. A., Pieri, L., Paul, G., Outeiro, T. F., Melki, R., Kallunki, P., Fog, K., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci43366 · Cited by 842
Blum-Degena, D., Müller, T., Kuhn, W., Gerlach, M., Przuntek, H., & Riederer, P. (1995) · Neuroscience Letters · doi:10.1016/0304-3940(95)12192-7 · Cited by 801
Does neuroinflammation fan the flame in neurodegenerative diseases?
Frank-Cannon, T. C., Alto, L. T., McAlpine, F. E., & Tansey, M. G. (2009) · Molecular Neurodegeneration · doi:10.1186/1750-1326-4-47 · Cited by 751
Toll‐like receptor 4 is required for α‐synuclein dependent activation of microglia and astroglia
Fellner, L., Irschick, R., Schanda, K., Reindl, M., Klimaschewski, L., Poewe, W., Wenning, G. K., & Stefanova, N. (2013) · Glia · doi:10.1002/glia.22437 · Cited by 697
α-Synuclein immunoreactivity in glial cytoplasmic inclusions in multiple system atrophy
Wakabayashi, K., Yoshimoto, M., Tsuji, S., & Takahashi, H. (1998) · Neuroscience Letters · doi:10.1016/s0304-3940(98)00407-8 · Cited by 643
The role of interleukin-1 in neuroinflammation and Alzheimer disease: an evolving perspective
Shaftel, S. S., Griffin, W. S. T., & O'Banion, M. K. (2008) · Journal of Neuroinflammation · doi:10.1186/1742-2094-5-7 · Cited by 565
Wang, J.-W., David, D. J., Monckton, J. E., Battaglia, F., & Hen, R. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.3632-07.2008 · Cited by 550
Mogi, M., Harada, M., Narabayashi, H., Inagaki, H., Minami, M., & Nagatsu, T. (1996) · Neuroscience Letters · doi:10.1016/0304-3940(96)12706-3 · Cited by 545
Braak, H., Sastre, M., & Del Tredici, K. (2007) · Acta Neuropathologica · doi:10.1007/s00401-007-0244-3 · Cited by 462 · cited 1×
“It is also important to note that a-syn accumulation is not restricted to neurons or oligodendrocytes, but it has also been observed within astroglial cells in MSA (Wenning and Jellinger, 2005), dementia with Lewy bodies (DLB) and PD (Braak et al., 2007; Lee et al., 2010b).”
BackgroundAntidepressants increase human hippocampal neurogenesis by activating the glucocorticoid receptor
Anacker, C., Zunszain, P. A., Cattaneo, A., Carvalho, L. A., Garabedian, M. J., Thuret, S., Price, J., & Pariante, C. M. (2011) · Molecular Psychiatry · doi:10.1038/mp.2011.26 · Cited by 435 · cited 2×
“…increase in neurogenesis are numerous; fluoxetine would increase neurogenesis through p21 inhibition and/or BDNF and GDNF regulation (Kohl et al., 2012; Pechnick et al., 2011; Ubhi et al., 2012) and amitriptyline through regulation of the glucocorticoid receptor (Anacker et al., 2011).”
BackgroundShaftel, S. S., Kyrkanides, S., Olschowka, J. A., Miller, J.-N. H., Johnson, R. E., & O’Banion, M. K. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31450 · Cited by 433 · cited 2×
“…a pro-inflammatory cytokine that is believed to drive the neuroinflammatory process (Mrak, 2009; Rothwell and Luheshi, 2000), and that is upregulated in AD, PD, multiple sclerosis, and other neurodegenerative diseases (Griffin et al., 1989, 2006; Rothwell and Luheshi, 2000; Shaftel et al., 2007).”
BackgroundKodama, M., Fujioka, T., & Duman, R. S. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.07.008 · Cited by 387 · cited 1×
“However, despite reports that olanzapine and amitriptyline also induce neurogenesis (Chadwick et al., 2011; Kodama et al., 2004), only fluoxetine increased hippocampal neurogenesis in both non-tg and MBP1-ha-syn tg mice, suggesting that antidepressant-induced cytokine changes are not directly…”
BackgroundSchwandner, R., Yamaguchi, K., & Cao, Z. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.191.7.1233 · Cited by 349 · cited 2×
“Both IL-1b and IL-17 can signal through the TRAF6-IKK signaling pathway (Cao et al., 1996; Schwandner et al., 2000), which results in the activation of NF-jB (Awane et al., 1999).”
BackgroundWakabayashi, K., Hayashi, S., Kakita, A., Yamada, M., Toyoshima, Y., Yoshimoto, M., & Takahashi, H. (1998) · Acta Neuropathologica · doi:10.1007/s004010050918 · Cited by 347 · cited 2×
“…characterized by the accumulation of a-syn aggregates within oligodendroglial cells (Dickson et al., 1999; Papp et al., 1989; Spillantini, 1999; Wakabayashi et al., 1998b), which is associated to neuronal loss in the striatum, cerebellum, brainstem and cortex, and that is accompanied by…”
BackgroundAntibody-Aided Clearance of Extracellular α-Synuclein Prevents Cell-to-Cell Aggregate Transmission
Bae, E.-J., Lee, H.-J., Rockenstein, E., Ho, D.-H., Park, E.-B., Yang, N.-Y., Desplats, P., Masliah, E., & Lee, S.-J. (2012) · The Journal of Neuroscience · doi:10.1523/jneurosci.1292-12.2012 · Cited by 339
Self-citationYazawa, I., Giasson, B. I., Sasaki, R., Zhang, B., Joyce, S., Uryu, K., Trojanowski, J. Q., & Lee, V. M.-Y. (2005) · Neuron · doi:10.1016/j.neuron.2005.01.032 · Cited by 301
Jang, A., Lee, H., Suk, J., Jung, J., Kim, K., & Lee, S. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.06695.x · Cited by 281 · cited 2×
“Neurons overexpressing a-syn release asyn oligomers to the extracellular space by nontraditional exocytosis (Jang et al., 2010; Lee et al., 2005) and astrocytes are able to endocytose and accumulate a-syn of neuronal origin (Fellner et al., 2013; Lee et al., 2010b).”
BackgroundAlpha-synuclein cell-to-cell transfer and seeding in grafted dopaminergic neurons in vivo
Angot, E., Steiner, J. A., Lema Tomé, C. M., Ekström, P., Mattsson, B., Björklund, A., & Brundin, P. (2012) · PLoS ONE · doi:10.1371/journal.pone.0039465 · Cited by 270 · cited 1×
“Recent studies have focused on a-syn propagation and its relevance in the development of a-synucleinopathies (Angot et al., 2012; Bae et al., 2012; Desplats et al., 2009; Hansen et al., 2011; Lee et al., 2012; Li et al., 2008; Rockenstein et al., 2012).”
BackgroundShults, C. W., Rockenstein, E., Crews, L., Adame, A., Mante, M., Larrea, G., Hashimoto, M., Song, D., Iwatsubo, T., Tsuboi, K., et al. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.3527-05.2005 · Cited by 254 · cited 13×
“In the MSA brain, as well as in the tg mouse line MBP1-ha-syn, a-syn accumulation induces neurodegeneration, which is also accompanied by neuroinflammation (Sekiyama et al., 2012; Shults et al., 2005).”
BackgroundMethodInfluentialSelf-citationα-Synuclein activates stress signaling protein kinases in THP-1 cells and microglia
Klegeris, A., Pelech, S., Giasson, B. I., Maguire, J., Zhang, H., McGeer, E. G., & McGeer, P. L. (2008) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2006.11.013 · Cited by 227 · cited 1×
“Microglial cells stimulated by a combination of a-syn and interferon-c (IFN-c) are neurotoxic in vitro, and this effect is greater in the presence of mutant a-syn forms that are associated with familial Parkinson’s disease (PD) (Klegeris et al., 2008).”
BackgroundAnti-inflammatory effects of fluoxetine in lipopolysaccharide(LPS)-stimulated microglial cells
Liu, D., Wang, Z., Liu, S., Wang, F., Zhao, S., & Hao, A. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.04.033 · Cited by 221 · cited 6×
“MBP1-ha-syn tg mice showed increased levels of IL1b, IL-1ra, IL-13, IL-17, MIP-1a, G-CSF, and IFN-c, and decreased levels of IL-3, IL-6, IL-10, RANTES, MIP-2, IP10, I-TAC, and TREM-1 when compared to non-tg mice (Table 1).”
InfluentialBehr, G. A., Moreira, J. C. F., & Frey, B. N. (2012) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2012/609421 · Cited by 205 · cited 2×
“Several mechanisms have been proposed to explain how antidepressants exert their neuroprotective actions, such as augmentation of antioxidant defenses (Behr et al., 2012; Kotan et al., 2011), BDNF upregulation (Balu et al.”
BackgroundKotan, V. O., Sarandol, E., Kirhan, E., Ozkaya, G., & Kirli, S. (2011) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2011.03.021 · Cited by 149 · cited 1×
“…been proposed to explain how antidepressants exert their neuroprotective actions, such as augmentation of antioxidant defenses (Behr et al., 2012; Kotan et al., 2011), BDNF upregulation (Balu et al., 2008; Shimizu et al., 2003; Ubhi et al., 2012) and noradrenergic regulation (Cohen et al., 1980;…”
BackgroundUbhi, K., Rockenstein, E., Mante, M., Inglis, C., Adame, A., Patrick, C., Whitney, K., & Masliah, E. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.0567-10.2010 · Cited by 147 · cited 2×
“These animals display motor abnormalities and olfactory alterations associated with MSA (Ubhi et al., 2010), together with decreased dendritic density and loss of dopaminergic fibers in the basal ganglia (Shults et al., 2005).”
BackgroundSelf-citationHisaoka, K., Nishida, A., Koda, T., Miyata, M., Zensho, H., Morinobu, S., Ohta, M., & Yamawaki, S. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00531.x · Cited by 133 · cited 1×
“…increase in neurogenesis (Malberg et al., 2000), improvement in learning and memory (Knegtering et al., 1994; Valluzzi and Chan, 2007; Yau et al., 2002), and elevation in the levels of neurotrophic factors and phosphorylated CREB (Balu et al., 2008; Hisaoka et al., 2001, 2008; Ubhi et al., 2012).”
BackgroundFluoxetine protects neurons against microglial activation-mediated neurotoxicity
Zhang, F., Zhou, H., Wilson, B. C., Shi, J.-S., Hong, J.-S., & Gao, H.-M. (2012) · Parkinsonism & Related Disorders · doi:10.1016/s1353-8020(11)70066-9 · Cited by 123 · cited 3×
“Fluoxetine protects neurons against microglia-mediated neurotoxicity in vitro, by inhibiting microglial NF-jB activation and the consequent decrease in the production of proinflammatory factors (Zhang et al., 2012).”
BackgroundLaifenfeld, D., Karry, R., Grauer, E., Klein, E., & Ben-Shachar, D. (2005) · Neurobiology of Disease · doi:10.1016/j.nbd.2005.03.023 · Cited by 103
Fluoxetine rescues impaired hippocampal neurogenesis in a transgenic A53T synuclein mouse model
Kohl, Z., Winner, B., Ubhi, K., Rockenstein, E., Mante, M., Münch, M., Barlow, C., Carter, T., Masliah, E., & Winkler, J. (2012) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2011.07933.x · Cited by 101
Self-citationPechnick, R. N., Zonis, S., Wawrowsky, K., Cosgayon, R., Farrokhi, C., Lacayo, L., & Chesnokova, V. (2011) · PLoS ONE · doi:10.1371/journal.pone.0027290 · Cited by 78 · cited 2×
“The molecular mechanisms proposed for antidepressant-induced increase in neurogenesis are numerous; fluoxetine would increase neurogenesis through p21 inhibition and/or BDNF and GDNF regulation (Kohl et al., 2012; Pechnick et al., 2011; Ubhi et al., 2012) and amitriptyline through regulation of the glucocorticoid rece…”
Background
Cited by
Krystal, J. H., Abdallah, C. G., Averill, L. A., Kelmendi, B., Harpaz-Rotem, I., Sanacora, G., Southwick, S. M., & Duman, R. S. (2017) · Current Psychiatry Reports · doi:10.1007/s11920-017-0829-z · Cited by 145
Valera, E., Spencer, B., Mott, J., Trejo, M., Adame, A., Mante, M., Rockenstein, E., Troncoso, J. C., Beach, T. G., Masliah, E., et al. (2017) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2017.00329 · Cited by 55
“This abnormal protein accumulation is accompanied by neuroinflammation (Stefanova et al., 2007; Valera et al., 2014), demyelination (Matsuo et al., 1998; Wenning et al., 2008) and neurodegeneration (Jellinger, 2003; Ubhi et al., 2011).”
BackgroundInfluentialSelf-citationRamos-Miguel, A., Honer, W. G., Boyda, H. N., Sawada, K., Beasley, C. L., Procyshyn, R. M., & Barr, A. M. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2015.06.022 · Cited by 18
Resolving a paradox: antidepressants, neuroinflammation, and neurodegeneration
Rajkumar, R. P. (2024) · Exploration of Neuroprotective Therapy · doi:10.37349/ent.2024.00068 · Cited by 9
Metadata
- Authors
- Valera, E., Ubhi, K., Mante, M., Rockenstein, E., & Masliah, E.
- Venue
- Glia
- Publisher
- Wiley
- Published
- 2013-12-06
- Volume
- 62
- Issue
- 2
- Pages
- 317-337
- ISSN
- 0894-1491 (ISSN-L)
- 1098-1136
- OpenAlex
- W1880131416
- Cited by
- 77
- References
- 48
- FWCI
- 4.94
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.